CSF α-synuclein contributes to the differential diagnosis of Alzheimer disease

INTRODUCTION: The ability of Alzheimer disease (AD) cerebrospinal fluid (CSF) biomarkers [amyloid beta peptide 1–42 (Aβ(42)), total tau (t-tau) and phosphorylated tau (p-tau)] to discriminate AD from related disorders is limited. Biomarkers for other concomitant pathologies [e.g., CSF α-synuclein fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Shi, Min, Tang, Lu, Toledo, Jon B., Ginghina, Carmen, Wang, Hua, Aro, Patrick, Jensen, Poul H., Weintraub, Daniel, Chen-Plotkin, Alice S., Irwin, David J., Grossman, Murray, McCluskey, Leo, Elman, Lauren B., Wolk, David A., Lee, Edward B., Shaw, Leslie M., Trojanowski, John Q., Zhang, Jing
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097943/
https://ncbi.nlm.nih.gov/pubmed/29604263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2018.02.015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados